Skip to content
VertexFinder

The Zimbabwean Government Turns Down ‘One-Sided’ American Health Aid Deal Due to Information Fears

Health aid image
The proposed American funding was intended for initiatives for treating and preventing HIV/Aids, TB, and malaria.

The nation of Zimbabwe has rejected a major US healthcare agreement worth $367m (£272m) spanning five years because of Washington's insistence on confidential biological samples.

The decision became public after a internal memorandum dated December was leaked, revealing that Head of State Emmerson Mnangagwa felt the agreement was "lopsided".

A government spokesperson has since explained that the United States was demanding access to biological samples for research and commercial gain but was not willing to share the resulting advantages from any future treatments.

"We will now turn to the difficult and regrettable task of ending our support in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.

The US Embassy said the United States had provided over $1.9bn as health assistance to Zimbabwe over the last twenty years.

A doctors' association in Zimbabwe has urged further talks to secure a agreement agreeable to both sides so the nation's vital HIV treatment initiative can continue.

Wider Context

This development follows a comparable situation in neighbouring Kenya, where a court halted a related deal with the US following concerns were raised about the security of Kenyans' health data.

Since resuming the presidency last year, US President Donald Trump has reduced overseas assistance and closed the US Agency for International Development (USAID).

The agency had overseen aid for the American government, but Trump claimed its expenditure was "wasteful" and his administration was seeking direct bilateral agreements to enhance transparency and responsibility.

Based on statements, 16 African countries have so far signed these new health pacts, representing more than $18.3bn in committed funds.

Details of the Rejected Agreement

The funds for Zimbabwe was intended to funded "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"We are confident this partnership could have provided extraordinary benefits for Zimbabwean communities, especially the 1.2 million men, women and children presently receiving antiretroviral therapy through US-supported programmes," Tremont said.

However, government spokesperson Nick Mangwana said the proposed deal was "unfair".

"Our nation was requested to share its genetic material and health information for a long time, with no corresponding promise of benefiting from any medical innovations – like new medicines or tests – that could result from that provided information," Mangwana explained.

"Put simply, our country would supply the basic resources for medical research without any certainty that the end products would be accessible to our population if a new pandemic arise."

National Interest and Global Health

He also pointed out that the US's withdrawal from the World Health Organization (WHO) and its push of one-on-one deals were undermining structures previously set up via the international organization.

The spokesperson gave as an example its Pathogen Access and Benefit Sharing framework created to deal with potential pandemics.

"This mechanism is intended to guarantee that when a country contributes its samples, the benefits – such as vaccines and treatments – are distributed fairly, not monopolised exclusively by those with the resources to develop them."

Zimbabwe's reservations over the US deal "must not be interpreted as anti-American sentiment," he added.

"We welcome further dialogue with our American counterparts on how subsequent collaboration might be structured in a way that respects the sovereignty and dignity of each country."

Medical Community Reaction

Medical experts expressed it understood the government's concerns, but recommended that negotiations must proceed since much of the nation's Aids initiatives were funded by external financing.

"If technical issues exist, such as those relating to information security or agreement terms, these can often be resolved through technical clarification and mutually agreed protections," it added.

This impasse underscores the complex debate between receiving vital international aid and safeguarding a country's data in an increasingly data-driven world.

About the author

Kayla Green

A tech journalist and AI enthusiast with over a decade of experience covering digital transformation and emerging technologies.

VertexFinder

Type to search articles.